Publication

Promising clinical benefit rates in advanced cancers alongside potential biomarker correlation in a phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy

Bono, P.
; 
Pasanen, A.
; 
Verlingue, L.
; 
de Jonge, M. J. A.
; 
de Miguel, M. J.
; 
Skytta, T.
; 
Iivanainen, S.
; 
Shetty, S.
; 
Ma, Y. T.
; 
Graham, Donna
... show 7 more
Citations
Altmetric:
Abstract
Authors
Bono, P.
Pasanen, A.
Verlingue, L.
de Jonge, M. J. A.
de Miguel, M. J.
Skytta, T.
Iivanainen, S.
Shetty, S.
Ma, Y. T.
Graham, Donna
Arora, S. P.
Jaakkola, P.
Yap, C.
Jalkanen, S.
Hollmen, M.
Koivunen, J.
Minchom, A. R.
Affiliation
Terveystalo Hospital and University of Helsinki, Helsinki, Finland
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Bono P, Pasanen A, Verlingue L, de Jonge MJA, de Miguel MJ, Skytta T, et al. Promising clinical benefit rates in advanced cancers alongside potential biomarker correlation in a phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680300868.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625797
Embedded videos